Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:24:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” across federal agencies.
    Difference
    0.6%
    Check dated 2026-10-25T01:22:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, reflecting a website release update.
    Difference
    0.1%
    Check dated 2026-10-18T01:08:09.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now displays ClinicalTrials.gov revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T01:37:10.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    UI text on the history page was updated to display 'Find contact information' with a lowercase 'c' and to show 'Revision: v3.7.0' instead of 'Revision: v3.6.6'. This change represents a minor copy/edit and version labeling in the page’s history display.
    Difference
    0.2%
    Check dated 2026-09-20T00:17:29.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-09-05T22:24:43.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.